DOID:8692: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{DOID | {{DOID | ||
| | |alt_id=DOID:8878;;DOID:8879;;DOID:8910;;DOID:9066;;DOID:9126 | ||
|comment= | |comment= | ||
|created_by= | |created_by= | ||
| | |def= | ||
|derives_from= | |derives_from= | ||
|develops_from= | |develops_from= | ||
|disjoint_from= | |||
|has_quality= | |has_quality= | ||
|id=DOID:8692 | |||
|is_a=DOID:1240 | |||
|is_obsolete= | |||
|located_in= | |located_in= | ||
|name=myeloid leukemia | |||
|namespace=FANTOM | |||
|obo_creation_date= | |||
|part_of= | |part_of= | ||
|preceded_by= | |||
|property_value=IAO:0000412 file:/Users/cjm/Dropbox/fantom5/HumanDO.obo | |property_value=IAO:0000412 file:/Users/cjm/Dropbox/fantom5/HumanDO.obo | ||
| | |subset= | ||
| | |synonym="LEUKEMIA MYELOGENOUS" EXACT [MTH:NOCODE];;"Myelogenous Leukemia in Remission" EXACT [NCI2004_11_17:C4899];;"myeloid granulocytic leukemia" EXACT [CSP2005:2004-4431];;"Myeloid leukaemia" EXACT [SNOMEDCT_2005_07_31:154587007];;"Myeloid leukaemia" EXACT [SNOMEDCT_2005_07_31:269631008];;"Myeloid leukaemia (category)" EXACT [SNOMEDCT_2005_07_31:128934006];;"Myeloid leukemia" EXACT [ICD9CM_2006:205];;"Myeloid leukemia (disorder)" EXACT [SNOMEDCT_2005_07_31:188732008];;"Myeloid leukemia in remission (disorder)" EXACT [SNOMEDCT_2005_07_31:94716000];;"Myeloid leukemia NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:188743000];;"Myeloid leukemia, disease (disorder)" EXACT [SNOMEDCT_2005_07_31:324170002];;"Myeloid leukemia, disease [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:94717009];;"Myeloid leukemia, no ICD-O subtype (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:37810007];;"Myeloid leukemia, NOS, without mention of remission" EXACT [SNOMEDCT_2005_07_31:94717009];;"Myeloid leukemias (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:190047005];;"Non-Lymphocytic Leukemia" EXACT [NCI2004_11_17:C3172];;"Other myeloid leukemia" EXACT [];;"Other myeloid leukemia (disorder)" EXACT [SNOMEDCT_2005_07_31:188740002];;"Other myeloid leukemia (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:190159007];;"Other myeloid leukemia in remission" EXACT [];;"Other myeloid leukemia NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:188742005];;"Other myeloid leukemia NOS (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:190051007];;"Other myeloid leukemia without mention of remission" EXACT [];;"Unspecified myeloid leukemia in remission" EXACT [];;"Unspecified myeloid leukemia without mention of remission" EXACT [] | ||
|union_of= | |||
|xref=ICD9CM:205;;ICD9CM:205.9;;MSH:D007951;;MSH:D015473;;NCI:C3172;;SNOMEDCT_2010_1_31:128934006;;SNOMEDCT_2010_1_31:154587007;;SNOMEDCT_2010_1_31:188732008;;SNOMEDCT_2010_1_31:188743000;;SNOMEDCT_2010_1_31:190047005;;SNOMEDCT_2010_1_31:269631008;;SNOMEDCT_2010_1_31:324170002;;SNOMEDCT_2010_1_31:37810007;;SNOMEDCT_2010_1_31:94717009;;UMLS_CUI:C0023470 | |||
}} | }} |
Latest revision as of 16:52, 12 September 2014
Name: | myeloid leukemia | ||
---|---|---|---|
Namespace: | FANTOM | ||
Xrefs: |
| ||
Synonyms: |
"LEUKEMIA MYELOGENOUS" EXACT [MTH:NOCODE] "Myelogenous Leukemia in Remission" EXACT [NCI2004_11_17:C4899] "myeloid granulocytic leukemia" EXACT [CSP2005:2004-4431] "Myeloid leukaemia" EXACT [SNOMEDCT_2005_07_31:154587007] "Myeloid leukaemia" EXACT [SNOMEDCT_2005_07_31:269631008] "Myeloid leukaemia (category)" EXACT [SNOMEDCT_2005_07_31:128934006] "Myeloid leukemia" EXACT [ICD9CM_2006:205] "Myeloid leukemia (disorder)" EXACT [SNOMEDCT_2005_07_31:188732008] "Myeloid leukemia in remission (disorder)" EXACT [SNOMEDCT_2005_07_31:94716000] "Myeloid leukemia NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:188743000] "Myeloid leukemia, disease (disorder)" EXACT [SNOMEDCT_2005_07_31:324170002] "Myeloid leukemia, disease [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:94717009] "Myeloid leukemia, no ICD-O subtype (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:37810007] "Myeloid leukemia, NOS, without mention of remission" EXACT [SNOMEDCT_2005_07_31:94717009] "Myeloid leukemias (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:190047005] "Non-Lymphocytic Leukemia" EXACT [NCI2004_11_17:C3172] "Other myeloid leukemia" EXACT [] "Other myeloid leukemia (disorder)" EXACT [SNOMEDCT_2005_07_31:188740002] "Other myeloid leukemia (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:190159007] "Other myeloid leukemia in remission" EXACT [] "Other myeloid leukemia NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:188742005] "Other myeloid leukemia NOS (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:190051007] "Other myeloid leukemia without mention of remission" EXACT [] "Unspecified myeloid leukemia in remission" EXACT [] "Unspecified myeloid leukemia without mention of remission" EXACT [] | ||
Alt_id: |
DOID:8878 DOID:8879 DOID:8910 DOID:9066 DOID:9126 |
Ontology association<br>Each term has an is_a parent in the Disease Ontology, which has a linkage to an another entity and FANTOM5 samples.Libraries were grouped into mutually exclusive facets according to the FANTOM5 sample ontology mapping to DISEASE ontologies.<br><br>link to ontology dataset<br>data
Parents
is_a: | DOID:1240(leukemia) |
---|
Children
is a: | DOID:8552 (chronic myeloid leukemia),DOID:9119 (acute myeloid leukemia) |
---|
Ontology Tree: Loaded from BioPortal
Ontorolgy tree(Small window open)
FF samples
Human (Homo sapiens)
- 10399-106A3 (acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh))
- 10400-106A4 (acute myeloid leukemia (FAB M5) cell line:THP-1 (revived))
- 10405-106A9 (acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed))
- 10409-106B4 (chronic myelogenous leukemia cell line:KU812)
- 10454-106G4 (chronic myelogenous leukemia cell line:K562)
- 10699-109G6 (acute myeloid leukemia (FAB M7) cell line:M-MOK)
- 10718-109I7 (biphenotypic B myelomonocytic leukemia cell line:MV-4-11)
- 10752-110D5 (leukemia, chronic megakaryoblastic cell line:MEG-01)
- 10761-110E5
- 10764-110E8 (acute myeloid leukemia (FAB M5) cell line:NOMO-1)
... further results Mouse (Mus musculus)
- 10399-106A3 (acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh))
- 10400-106A4 (acute myeloid leukemia (FAB M5) cell line:THP-1 (revived))
- 10405-106A9 (acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed))
- 10409-106B4 (chronic myelogenous leukemia cell line:KU812)
- 10454-106G4 (chronic myelogenous leukemia cell line:K562)
- 10699-109G6 (acute myeloid leukemia (FAB M7) cell line:M-MOK)
- 10718-109I7 (biphenotypic B myelomonocytic leukemia cell line:MV-4-11)
- 10752-110D5 (leukemia, chronic megakaryoblastic cell line:MEG-01)
- 10761-110E5
- 10764-110E8 (acute myeloid leukemia (FAB M5) cell line:NOMO-1)
Enrichment analysis: top 100 FFCP enriched with this ontology termTOP 100 FANTOM5 Cage Peaks enriched with DOID:8692 (myeloid leukemia), sorted by p-values <br>Analyst: Hideya Kawaji<br><br>link to source dataset <br>human : data <br>mouse : data
P-value | FFCP | Short description |
---|---|---|
5.17e-119 | FFCP PHASE2:Hg19::chr6:68598314..68598325,-#_592044a2434645483cf925012b6bba26 | p@chr6:68598314..68598325, - |
5.17e-119 | FFCP PHASE1:Hg19::chr6:68598314..68598325,-#_592044a2434645483cf925012b6bba26 | p@chr6:68598314..68598325, - |
2.45e-115 | FFCP PHASE2:Hg19::chr6:68598272..68598298,-#_00bce4cf8a8176fc22d257f3cfbb32e9 | p@chr6:68598272..68598298, - |
2.45e-115 | FFCP PHASE1:Hg19::chr6:68598272..68598298,-#_00bce4cf8a8176fc22d257f3cfbb32e9 | p@chr6:68598272..68598298, - |
9.64e-113 | FFCP PHASE1:Hg19::chr6:68596384..68596400,-#_ef875d98e5095f9245d965f5a26ea836 | p@chr6:68596384..68596400, - |
9.64e-113 | FFCP PHASE2:Hg19::chr6:68596384..68596400,-#_ef875d98e5095f9245d965f5a26ea836 | p@chr6:68596384..68596400, - |
9.04e-108 | FFCP PHASE1:Hg19::chr6:68592986..68593000,-#_e18dc17ce3c6bc45614762d5e51f4b3e | p@chr6:68592986..68593000, - |
9.04e-108 | FFCP PHASE2:Hg19::chr6:68592986..68593000,-#_e18dc17ce3c6bc45614762d5e51f4b3e | p@chr6:68592986..68593000, - |
9.6e-108 | FFCP PHASE2:Hg19::chr6:68598245..68598268,-#_53cf22b6eddc1884d054b7916c8e5561 | p@chr6:68598245..68598268, - |
9.6e-108 | FFCP PHASE1:Hg19::chr6:68598245..68598268,-#_53cf22b6eddc1884d054b7916c8e5561 | p@chr6:68598245..68598268, - |
4.74e-107 | FFCP PHASE2:Hg19::chr16:29674970..29675007,+#_e46193636e435b50c39d1d6870aa5546 | p4@SPN |
4.74e-107 | FFCP PHASE1:Hg19::chr16:29674970..29675007,+#_e46193636e435b50c39d1d6870aa5546 | p4@SPN |
7.65e-107 | FFCP PHASE2:Hg19::chr6:68598507..68598519,-#_e8598a4afd686b713a53aef6252fb888 | p@chr6:68598507..68598519, - |
7.65e-107 | FFCP PHASE1:Hg19::chr6:68598507..68598519,-#_e8598a4afd686b713a53aef6252fb888 | p@chr6:68598507..68598519, - |
1.74e-106 | FFCP PHASE2:Hg19::chr6:68598587..68598598,-#_26db9efbe7622e5b9ac5d2659ae8aa2e | p@chr6:68598587..68598598, - |
1.74e-106 | FFCP PHASE1:Hg19::chr6:68598587..68598598,-#_26db9efbe7622e5b9ac5d2659ae8aa2e | p@chr6:68598587..68598598, - |
3.12e-102 | FFCP PHASE1:Hg19::chr11:33913475..33913549,-#_439f1996fe65b219290de45bb6c7b3d4 | p5@LMO2 |
3.12e-102 | FFCP PHASE2:Hg19::chr11:33913475..33913549,-#_439f1996fe65b219290de45bb6c7b3d4 | p5@LMO2 |
1.29e-100 | FFCP PHASE1:Hg19::chr6:68591611..68591627,-#_3794a407a3f51d82607a73beddd2ca59 | p@chr6:68591611..68591627, - |
1.29e-100 | FFCP PHASE2:Hg19::chr6:68591611..68591627,-#_3794a407a3f51d82607a73beddd2ca59 | p@chr6:68591611..68591627, - |
1.29e-100 | FFCP PHASE1:Hg19::chr6:68593536..68593560,-#_3794a407a3f51d82607a73beddd2ca59 | p@chr6:68593536..68593560, - |
1.29e-100 | FFCP PHASE2:Hg19::chr6:68593536..68593560,-#_3794a407a3f51d82607a73beddd2ca59 | p@chr6:68593536..68593560, - |
3.05e-100 | FFCP PHASE2:Hg19::chr6:68596826..68596859,-#_c1dc5119f1f6c2562c6776633d1fd110 | p@chr6:68596826..68596859, - |
3.05e-100 | FFCP PHASE1:Hg19::chr6:68596826..68596859,-#_c1dc5119f1f6c2562c6776633d1fd110 | p@chr6:68596826..68596859, - |
3.05e-100 | FFCP PHASE2:Hg19::chr6:68597599..68597612,-#_c1dc5119f1f6c2562c6776633d1fd110 | p@chr6:68597599..68597612, - |
3.05e-100 | FFCP PHASE2:Hg19::chr6:68596698..68596715,-#_c1dc5119f1f6c2562c6776633d1fd110 | p@chr6:68596698..68596715, - |
3.05e-100 | FFCP PHASE1:Hg19::chr6:68597599..68597612,-#_c1dc5119f1f6c2562c6776633d1fd110 | p@chr6:68597599..68597612, - |
3.05e-100 | FFCP PHASE1:Hg19::chr6:68596698..68596715,-#_c1dc5119f1f6c2562c6776633d1fd110 | p@chr6:68596698..68596715, - |
2.22e-94 | FFCP PHASE1:Hg19::chr6:68595369..68595417,-#_f6a8e8f30050b6d5cf208ec6bfab83fb | p@chr6:68595369..68595417, - |
2.22e-94 | FFCP PHASE1:Hg19::chr6:68593520..68593534,-#_f6a8e8f30050b6d5cf208ec6bfab83fb | p@chr6:68593520..68593534, - |
2.22e-94 | FFCP PHASE2:Hg19::chr6:68593520..68593534,-#_f6a8e8f30050b6d5cf208ec6bfab83fb | p@chr6:68593520..68593534, - |
2.22e-94 | FFCP PHASE2:Hg19::chr6:68595369..68595417,-#_f6a8e8f30050b6d5cf208ec6bfab83fb | p@chr6:68595369..68595417, - |
5.19e-94 | FFCP PHASE1:Hg19::chr6:68596783..68596797,-#_1915ecbbc6c7a14ad999d4a1103fd535 | p@chr6:68596783..68596797, - |
5.19e-94 | FFCP PHASE2:Hg19::chr6:68596343..68596355,-#_1915ecbbc6c7a14ad999d4a1103fd535 | p@chr6:68596343..68596355, - |
5.19e-94 | FFCP PHASE2:Hg19::chr6:68596783..68596797,-#_1915ecbbc6c7a14ad999d4a1103fd535 | p@chr6:68596783..68596797, - |
5.19e-94 | FFCP PHASE1:Hg19::chr6:68596343..68596355,-#_1915ecbbc6c7a14ad999d4a1103fd535 | p@chr6:68596343..68596355, - |
2.16e-93 | FFCP PHASE2:Hg19::chr12:58329776..58329791,-#_28fd3ede83ad5ecca3e88d212b27915f | p3@ENST00000547492 |
2.16e-93 | FFCP PHASE1:Hg19::chr12:58329776..58329791,-#_28fd3ede83ad5ecca3e88d212b27915f | p3@ENST00000547492 |
2.3e-93 | FFCP PHASE2:Hg19::chr16:29675010..29675041,+#_bace72c1a831070a91aae056a6892b94 | p5@SPN |
2.3e-93 | FFCP PHASE1:Hg19::chr16:29675010..29675041,+#_bace72c1a831070a91aae056a6892b94 | p5@SPN |
1.84e-90 | FFCP PHASE1:Hg19::chr6:135513595..135513617,+#_7b16eca14af1691894c5386548426a08 | p4@MYB |
1.84e-90 | FFCP PHASE2:Hg19::chr6:135513595..135513617,+#_7b16eca14af1691894c5386548426a08 | p4@MYB |
7.75e-89 | FFCP PHASE2:Hg19::chr6:68596289..68596302,-#_0a250b49b6a1d989524042a0a816b735 | p@chr6:68596289..68596302, - |
7.75e-89 | FFCP PHASE1:Hg19::chr6:68596289..68596302,-#_0a250b49b6a1d989524042a0a816b735 | p@chr6:68596289..68596302, - |
3.71e-88 | FFCP PHASE1:Hg19::chr6:68592948..68592958,-#_1d931f894de404227ff5c8f77f6043fb | p@chr6:68592948..68592958, - |
3.71e-88 | FFCP PHASE2:Hg19::chr6:68592948..68592958,-#_1d931f894de404227ff5c8f77f6043fb | p@chr6:68592948..68592958, - |
3.94e-88 | FFCP PHASE2:Hg19::chr6:68598534..68598555,-#_4a60adce00ea2941868958cb6e3bd84b | p@chr6:68598534..68598555, - |
3.94e-88 | FFCP PHASE1:Hg19::chr6:68598534..68598555,-#_4a60adce00ea2941868958cb6e3bd84b | p@chr6:68598534..68598555, - |
4.46e-88 | FFCP PHASE1:Hg19::chr6:68593264..68593275,-#_28619220c6a520514e110ae8a731efa1 | p@chr6:68593264..68593275, - |
4.46e-88 | FFCP PHASE2:Hg19::chr6:68593264..68593275,-#_28619220c6a520514e110ae8a731efa1 | p@chr6:68593264..68593275, - |
8.57e-88 | FFCP PHASE1:Hg19::chr6:68597438..68597450,-#_0da74ce1b445a3abf766b57ce1959ee6 | p@chr6:68597438..68597450, - |
8.57e-88 | FFCP PHASE1:Hg19::chr6:68593587..68593600,-#_0da74ce1b445a3abf766b57ce1959ee6 | p@chr6:68593587..68593600, - |
8.57e-88 | FFCP PHASE2:Hg19::chr6:68593587..68593600,-#_0da74ce1b445a3abf766b57ce1959ee6 | p@chr6:68593587..68593600, - |
8.57e-88 | FFCP PHASE1:Hg19::chr6:68593250..68593259,-#_0da74ce1b445a3abf766b57ce1959ee6 | p@chr6:68593250..68593259, - |
8.57e-88 | FFCP PHASE2:Hg19::chr6:68593250..68593259,-#_0da74ce1b445a3abf766b57ce1959ee6 | p@chr6:68593250..68593259, - |
8.57e-88 | FFCP PHASE2:Hg19::chr6:68596757..68596769,-#_0da74ce1b445a3abf766b57ce1959ee6 | p@chr6:68596757..68596769, - |
8.57e-88 | FFCP PHASE1:Hg19::chr6:68596757..68596769,-#_0da74ce1b445a3abf766b57ce1959ee6 | p@chr6:68596757..68596769, - |
8.57e-88 | FFCP PHASE2:Hg19::chr6:68597438..68597450,-#_0da74ce1b445a3abf766b57ce1959ee6 | p@chr6:68597438..68597450, - |
5.52e-85 | FFCP PHASE1:Hg19::chr19:695494..695510,-#_5ee0be624e7ddb07321e6926ce14be31 | p3@PRSS57 |
5.52e-85 | FFCP PHASE2:Hg19::chr19:695494..695510,-#_5ee0be624e7ddb07321e6926ce14be31 | p3@PRSS57 |
2.57e-82 | FFCP PHASE1:Hg19::chr6:68593206..68593218,-#_def2b3423cf3b3fd2083dc6b36f3c1a6 | p@chr6:68593206..68593218, - |
2.57e-82 | FFCP PHASE2:Hg19::chr6:68593206..68593218,-#_def2b3423cf3b3fd2083dc6b36f3c1a6 | p@chr6:68593206..68593218, - |
5.22e-82 | FFCP PHASE1:Hg19::chr11:33913558..33913630,-#_256d933c99dd9022a255a445a0c6a940 | p4@LMO2 |
5.22e-82 | FFCP PHASE2:Hg19::chr11:33913558..33913630,-#_256d933c99dd9022a255a445a0c6a940 | p4@LMO2 |
1.37e-81 | FFCP PHASE2:Hg19::chr6:68598642..68598649,-#_8666f9191040fa9ef9129254f6e9633f | p@chr6:68598642..68598649, - |
1.37e-81 | FFCP PHASE2:Hg19::chr6:68598190..68598207,-#_8666f9191040fa9ef9129254f6e9633f | p@chr6:68598190..68598207, - |
1.37e-81 | FFCP PHASE2:Hg19::chr6:68595490..68595501,-#_8666f9191040fa9ef9129254f6e9633f | p@chr6:68595490..68595501, - |
1.37e-81 | FFCP PHASE2:Hg19::chr1:246350204..246350229,-#_8666f9191040fa9ef9129254f6e9633f | p@chr1:246350204..246350229, - |
1.37e-81 | FFCP PHASE1:Hg19::chr6:68598642..68598649,-#_8666f9191040fa9ef9129254f6e9633f | p@chr6:68598642..68598649, - |
1.37e-81 | FFCP PHASE1:Hg19::chr6:68598190..68598207,-#_8666f9191040fa9ef9129254f6e9633f | p@chr6:68598190..68598207, - |
1.37e-81 | FFCP PHASE2:Hg19::chr6:68594786..68594797,-#_8666f9191040fa9ef9129254f6e9633f | p@chr6:68594786..68594797, - |
1.37e-81 | FFCP PHASE1:Hg19::chr6:68595490..68595501,-#_8666f9191040fa9ef9129254f6e9633f | p@chr6:68595490..68595501, - |
1.37e-81 | FFCP PHASE2:Hg19::chr6:68595866..68595871,-#_8666f9191040fa9ef9129254f6e9633f | p@chr6:68595866..68595871, - |
1.37e-81 | FFCP PHASE1:Hg19::chr6:68594786..68594797,-#_8666f9191040fa9ef9129254f6e9633f | p@chr6:68594786..68594797, - |
1.37e-81 | FFCP PHASE1:Hg19::chr6:68595866..68595871,-#_8666f9191040fa9ef9129254f6e9633f | p@chr6:68595866..68595871, - |
1.37e-81 | FFCP PHASE1:Hg19::chr1:246350204..246350229,-#_8666f9191040fa9ef9129254f6e9633f | p@chr1:246350204..246350229, - |
5.76e-80 | FFCP PHASE2:Hg19::chr12:58329793..58329806,-#_3d87651c9a3554e2ad469f0659d84e0d | p2@ENST00000547492 |
5.76e-80 | FFCP PHASE1:Hg19::chr12:58329793..58329806,-#_3d87651c9a3554e2ad469f0659d84e0d | p2@ENST00000547492 |
7.15e-80 | FFCP PHASE2:Hg19::chr12:58329762..58329773,-#_4819ab8efe96b1eda738a6d484fab048 | p5@ENST00000547492 |
7.15e-80 | FFCP PHASE1:Hg19::chr12:58329762..58329773,-#_4819ab8efe96b1eda738a6d484fab048 | p5@ENST00000547492 |
2.02e-77 | FFCP PHASE2:Hg19::chr6:68599042..68599067,-#_13d7cb9d1e873e3f173c292716b6980d | p1@uc003pes.1, p1@uc003pet.1 |
2.02e-77 | FFCP PHASE1:Hg19::chr6:68599042..68599067,-#_13d7cb9d1e873e3f173c292716b6980d | p1@uc003pes.1, p1@uc003pet.1 |
9.17e-77 | FFCP PHASE1:Hg19::chr6:68593158..68593168,-#_c1b3ad390e8cec3feb187817bffde2b0 | p@chr6:68593158..68593168, - |
9.17e-77 | FFCP PHASE2:Hg19::chr6:68593158..68593168,-#_c1b3ad390e8cec3feb187817bffde2b0 | p@chr6:68593158..68593168, - |
1.66e-76 | FFCP PHASE1:Hg19::chr3:129297361..129297381,-#_54a8d98eb02c57a86adff03c403ae113 | p10@PLXND1 |
1.66e-76 | FFCP PHASE2:Hg19::chr3:129297361..129297381,-#_54a8d98eb02c57a86adff03c403ae113 | p10@PLXND1 |
9.78e-76 | FFCP PHASE2:Hg19::chr1:246269797..246269820,-#_23f6f34d9dc1cb87be3c91b40b84d91a | p@chr1:246269797..246269820, - |
9.78e-76 | FFCP PHASE1:Hg19::chr1:246269797..246269820,-#_23f6f34d9dc1cb87be3c91b40b84d91a | p@chr1:246269797..246269820, - |
1.3e-75 | FFCP PHASE2:Hg19::chr6:68598984..68598997,-#_5b44f6651ce7d6c22f47cceb067920c3 | p2@uc003pes.1, p2@uc003pet.1 |
1.3e-75 | FFCP PHASE1:Hg19::chr6:68598984..68598997,-#_5b44f6651ce7d6c22f47cceb067920c3 | p2@uc003pes.1, p2@uc003pet.1 |
1.92e-75 | FFCP PHASE2:Hg19::chr19:695576..695587,-#_eefb637c675628c8f907fef11a34a006 | p4@PRSS57 |
1.92e-75 | FFCP PHASE1:Hg19::chr19:695576..695587,-#_eefb637c675628c8f907fef11a34a006 | p4@PRSS57 |
2.14e-75 | FFCP PHASE2:Hg19::chr6:68598473..68598480,-#_f309833b2a1e99d92041cc58047650fe | p@chr6:68598473..68598480, - |
2.14e-75 | FFCP PHASE2:Hg19::chr6:68598674..68598685,-#_f309833b2a1e99d92041cc58047650fe | p@chr6:68598674..68598685, - |
2.14e-75 | FFCP PHASE1:Hg19::chr6:68598473..68598480,-#_f309833b2a1e99d92041cc58047650fe | p@chr6:68598473..68598480, - |
2.14e-75 | FFCP PHASE1:Hg19::chr6:68598674..68598685,-#_f309833b2a1e99d92041cc58047650fe | p@chr6:68598674..68598685, - |
2.95e-75 | FFCP PHASE1:Hg19::chr19:695467..695482,-#_2bc36cfe9ebe6843ab6425d5ff2b7d40 | p2@PRSS57 |
2.95e-75 | FFCP PHASE2:Hg19::chr19:695467..695482,-#_2bc36cfe9ebe6843ab6425d5ff2b7d40 | p2@PRSS57 |
7.95e-75 | FFCP PHASE1:Hg19::chr4:80132811..80132835,+#_4325d692b7fa7c3de87dc131e0098a6b | p1@ENST00000437737 |
7.95e-75 | FFCP PHASE2:Hg19::chr4:80132811..80132835,+#_4325d692b7fa7c3de87dc131e0098a6b | p1@ENST00000437737 |